Thirty-day VARC-2 and performance data of a new self-expanding transcatheter aortic heart valve
EuroIntervention 2015;10:785-792 published online ahead of aprint May 2015. DOI: 10.4244/EIJY15M05_05
Hendrik Treede1*, MD; Edith Lubos2, MD; Lenard Conradi1, MD; Florian Deuschl2, MD; Federico M. Asch3, MD; Neil J. Weissman3, MD; Niklas Schofer2, MD; Johannes Schirmer1, MD; Dietmar Koschyk2, MD; Stefan Blankenberg2, MD; Hermann Reichenspurner1, MD, PhD; Ulrich Schaefer2, MD
1. Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany; 2. Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany; 3. MedStar Cardiovascular Research Network at Washington
Aims: Transcatheter aortic valve therapy has become an established procedure for patients at high risk for surgical valve replacement. The BIOVALVE-I study aims to assess the safety and p